The Valley Desk

Healthcare research from Johnson & Johnson, page 33

A filtered view. Show the full list.

Refine

817 publications and 7 software projects · listings 769–792

Listings

  1. ArticleFrontiers in oncology

    A discrete choice experiment analysis to understand patient preferences for multiple myeloma treatments

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  2. ArticleFrontiers in oncology

    Time and cost burden associated with docetaxel in patients with metastatic castration-sensitive prostate cancer initiating an androgen receptor pathway inhibitor-based regimen

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  3. ArticleFrontiers in pharmacology

    Regulatory-required post-marketing database studies in Japan could be leveraged to assess important potential risks as well as identified risks

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Research dataAdded

  4. ReviewCurrent oncology (Toronto, Ont.)

    Resistance Mutation Profiles Associated with Current Treatments for Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer in the United States: A Systematic Literature Review

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  5. ArticleJournal of market access & health policy

    Patient Perspectives on Health Insurance Design: A Mixed-Methods Analysis

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  6. ArticleViruses

    Dengue Infections Among Household Contacts of Symptomatic Index Cases: Implications for Community-Based Intervention Studies

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  7. ArticleVaccines

    Effectiveness of Heterologous and Homologous Ad26.COV2.S Vaccine Boosting in Preventing COVID-19-Related Outcomes Among Individuals with a Completed Primary Vaccination Series in the United States

    Listed An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  8. ArticleVaccines

    A Prospective Cohort Study of Primary Dengue Virus Infection in Medellín, Colombia

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  9. ArticleJournal of health economics and outcomes research

    Assessing Upfront Treatment Patterns for Newly Initiated Patients With Pulmonary Arterial Hypertension in the United States

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  10. ArticleJournal of health economics and outcomes research

    Prostate-Specific Antigen Reduction After Androgen Receptor Pathway Inhibitor Initiation: Real-World Comparison of Disease Progression Among Patients With Metastatic Castration-Sensitive Prostate Cancer

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  11. ArticleJournal of health economics and outcomes research

    Healthcare Resource Use, Healthcare Costs, and Unmet Needs Among Patients Treated for EGFR-Mutated Advanced or Metastatic Non-small Cell Lung Cancer

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  12. Case reportThe Journal of rheumatology

    Patient Perspectives and Clinical Insights Into the Diagnostic Journey From Connective Tissue Disease to Pulmonary Arterial Hypertension

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  13. Clinical trial reportThe Journal of rheumatology

    Validity and Psychometric Properties of 3 and 4 Visual Analog Scale in Participants With Psoriatic Arthritis Treated With Guselkumab

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  14. Clinical trial reportThe Journal of clinical psychiatry

    Esketamine Nasal Spray vs Quetiapine Extended-Release: Examining Work Productivity Loss and Related Costs in Patients With Treatment-Resistant Depression

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  15. ArticleIJTLD open

    Clinical standards for antimicrobial stewardship in TB care

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  16. ArticleJournal of comparative effectiveness research

    A comparison of healthcare resource utilization and costs between patients with chronic lymphocytic leukemia treated with first-line ibrutinib or acalabrutinib using two large US real-world databases

    Verified Author affiliations on the Europe PMC record name Hospital of the University of Pennsylvania, Johnson & Johnson, Perelman School of Medicine, with Penn Medicine, University of Pennsylvania linked by the institution reference. Affiliation source

    Public healthAdded

  17. ArticleJournal of comparative effectiveness research

    Overall survival in patients with metastatic castration-sensitive prostate cancer treated with apalutamide versus abiraterone acetate: a head-to-head analysis of real-world patients in the USA

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  18. ArticleJournal of comparative effectiveness research

    Healthcare cost comparison between first-line ibrutinib and acalabrutinib in chronic lymphocytic leukemia patients in the Veterans Affairs

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  19. Clinical trial reportArthritis & rheumatology (Hoboken, N.J.)

    Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic-Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double-Blind, Placebo-Controlled APEX Study

    Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, with Drexel University linked by the institution reference. Affiliation source

    Clinical careAdded

  20. ArticleCancer

    Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies

    Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Johnson & Johnson. Affiliation source

    Clinical careAdded

  21. ArticleHemaSphere

    Dual targeting of BCMA and GPRC5D with the trispecific antibody ramantamig addresses antigenic heterogeneity in myeloma

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  22. ArticlePulmonary circulation

    A Team-Based Patient Engagement Approach to Selexipag Initiation and Maintenance in Pulmonary Arterial Hypertension (TEAM PAH): Real-World Dosing Patterns and Persistence Among Patients With and Without a History of Methamphetamine Use

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  23. ArticlePulmonary circulation

    Contemporary Economic, Hospitalization, and Mortality Burden Among Pulmonary Arterial Hypertension Patients: A Real-World US Claims Data Analysis

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  24. ArticleAdvances in therapy

    Real-World Characteristics, Treatment Patterns, and Clinical Outcomes of Patients Initiated on Macitentan/Tadalafil Single-Tablet Combination Therapy in the United States

    Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Temple University, Temple University Hospital, with Temple Health linked by the institution reference. Affiliation source

    Clinical careAdded